79 related articles for article (PubMed ID: 7629246)
1. There is no difference in spontaneous and 17 beta-estradiol-induced interleukin-1 beta release by peripheral blood mononuclear cells from nonosteoporotic women with different rates of early postmenopausal bone loss.
Høgåsen AK; Nordsletten L; Aasen AO; Falch JA
J Clin Endocrinol Metab; 1995 Aug; 80(8):2480-4. PubMed ID: 7629246
[TBL] [Abstract][Full Text] [Related]
2. Biochemical markers as predictors of rates of bone loss after menopause.
Rogers A; Hannon RA; Eastell R
J Bone Miner Res; 2000 Jul; 15(7):1398-404. PubMed ID: 10893690
[TBL] [Abstract][Full Text] [Related]
3. Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women.
Charatcharoenwitthaya N; Khosla S; Atkinson EJ; McCready LK; Riggs BL
J Bone Miner Res; 2007 May; 22(5):724-9. PubMed ID: 17295604
[TBL] [Abstract][Full Text] [Related]
4. 17 beta-Oestradiol and 1 alpha,25-dihydroxycholecalciferol modulate constitutive and bone matrix-induced interleukin-1 beta (IL-1 beta) production by peripheral blood mononuclear cells isolated from postmenopausal women.
Høgåsen AK; Nordsletten L; Aasen AO; Falch JA
Scand J Clin Lab Invest; 1998 Apr; 58(2):97-102. PubMed ID: 9587160
[TBL] [Abstract][Full Text] [Related]
5. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
6. Estrogen inhibits release of tumor necrosis factor from peripheral blood mononuclear cells in postmenopausal women.
Ralston SH; Russell RG; Gowen M
J Bone Miner Res; 1990 Sep; 5(9):983-8. PubMed ID: 2281828
[TBL] [Abstract][Full Text] [Related]
7. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
8. Bone resorption at the femoral neck is dependent on local factors in nonosteoporotic late postmenopausal women: an in vitro-in vivo study.
Cohen-Solal ME; Graulet AM; Gueris J; Denne MA; Bergot C; Morieux C; Sedel L; Kuntz D; De Vernejoul MC
J Bone Miner Res; 1995 Feb; 10(2):307-14. PubMed ID: 7754812
[TBL] [Abstract][Full Text] [Related]
9. Different effects of raloxifene and estrogen on interleukin-1beta and interleukin-1 receptor antagonist production using in vitro and ex vivo studies.
Rogers A; Clowes JA; Pereda CA; Eastell R
Bone; 2007 Jan; 40(1):105-10. PubMed ID: 16934544
[TBL] [Abstract][Full Text] [Related]
10. Circulating cytokine levels in osteoporotic and normal women.
Khosla S; Peterson JM; Egan K; Jones JD; Riggs BL
J Clin Endocrinol Metab; 1994 Sep; 79(3):707-11. PubMed ID: 8077350
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of osteoclast activating cytokines, interleukin-11 and transforming growth factor-beta2, as valuable biomarkers for the assessment of bone turnover in postmenopausal osteoporosis.
Shaarawy M; Zaki S; Sheiba M; El-Minawi AM
Clin Lab; 2003; 49(11-12):625-36. PubMed ID: 14651333
[TBL] [Abstract][Full Text] [Related]
12. Effects of estrogen in vivo and in vitro on spontaneous interleukin-1 release by monocytes from postmenopausal women.
Stock JL; Coderre JA; McDonald B; Rosenwasser LJ
J Clin Endocrinol Metab; 1989 Feb; 68(2):364-8. PubMed ID: 2783934
[TBL] [Abstract][Full Text] [Related]
13. Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients.
Kushida K; Takahashi M; Kawana K; Inoue T
J Clin Endocrinol Metab; 1995 Aug; 80(8):2447-50. PubMed ID: 7629240
[TBL] [Abstract][Full Text] [Related]
14. Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis.
Hustmyer FG; Walker E; Yu XP; Girasole G; Sakagami Y; Peacock M; Manolagas SC
J Bone Miner Res; 1993 Jan; 8(1):51-9. PubMed ID: 8427049
[TBL] [Abstract][Full Text] [Related]
15. Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling.
Pineda B; Hermenegildo C; Tarín JJ; Cano A; García-Pérez MÁ
Menopause; 2012 Mar; 19(3):319-27. PubMed ID: 22067277
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
[TBL] [Abstract][Full Text] [Related]
17. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
[TBL] [Abstract][Full Text] [Related]
18. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.
Kimble RB; Vannice JL; Bloedow DC; Thompson RC; Hopfer W; Kung VT; Brownfield C; Pacifici R
J Clin Invest; 1994 May; 93(5):1959-67. PubMed ID: 8182127
[TBL] [Abstract][Full Text] [Related]
20. Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women.
Rachoń D; Myśliwska J; Suchecka-Rachoń K; Wieckiewicz J; Myśliwski A
J Endocrinol; 2002 Feb; 172(2):387-95. PubMed ID: 11834456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
